These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 667554)
1. Contamination of sterile fluids. Ayliffe G; Lowbury EJ; Phillips I; Williams JD Br Med J; 1978 Jul; 2(6130):123. PubMed ID: 667554 [No Abstract] [Full Text] [Related]
2. Needed: serious attention to sterile products. Myers CE Am J Health Syst Pharm; 1996 Nov; 53(21):2582. PubMed ID: 8913386 [No Abstract] [Full Text] [Related]
3. Program for bacterial surveillance of intravenous admixtures. Ravin R; Bahr J; Luscomb F; Gooch J; Mutter S; Spittell SD Am J Hosp Pharm; 1974 Apr; 31(4):340-7. PubMed ID: 4822023 [No Abstract] [Full Text] [Related]
4. Production of sterile fluids in hospital pharmacies. Gillett AP J Hosp Infect; 1981 Jun; 2(2):113-5. PubMed ID: 6174572 [No Abstract] [Full Text] [Related]
5. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations]. Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280 [TBL] [Abstract][Full Text] [Related]
6. Prolonged shutdown of an isolator because of false-positive sterility tests. Langouet AM; Marr A; Kountny E; Etienne F Am J Health Syst Pharm; 2001 May; 58(10):914-5. PubMed ID: 11381497 [No Abstract] [Full Text] [Related]
7. ASHP guidelines on compounding sterile preparations. American Society of Health System Pharmacists Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608 [No Abstract] [Full Text] [Related]
8. ASHP gears up multistep action plan regarding sterile drug products. Am J Hosp Pharm; 1991 Mar; 48(3):386, 389-90. PubMed ID: 2028985 [No Abstract] [Full Text] [Related]
10. Auditing sterile compounding competency with video observation. Connor TK; Lim JH; Hinton TM Am J Health Syst Pharm; 2017 Aug; 74(16):1218-1219. PubMed ID: 28790073 [No Abstract] [Full Text] [Related]
11. Environmental monitoring of sterile fluid production facilities. Deeks T J Hosp Infect; 1982 Jun; 3(2):201-3. PubMed ID: 6181140 [No Abstract] [Full Text] [Related]
12. Evaluation of two sterility testing methods for intravenous admixtures. Condella F; Eichelberger K; Foote LC; Griffin RE Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270 [TBL] [Abstract][Full Text] [Related]
13. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations. Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200 [TBL] [Abstract][Full Text] [Related]
14. The Medicines Act 1968--its impact on the hospital pharmacist in relation to sterile products. Sprake JM Hosp Eng; 1978 Oct; 32(8):24-7. PubMed ID: 10239209 [No Abstract] [Full Text] [Related]
15. Demand clean vials. Power LA Am J Health Syst Pharm; 2005 Mar; 62(5):471. PubMed ID: 15745909 [No Abstract] [Full Text] [Related]
16. Control of the aseptic processing environment. Frieben WR Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522 [TBL] [Abstract][Full Text] [Related]
17. Contamination of fluids from a hospital pharmacy. Joynson DH; Howells CH; Liddington R; Williams A J Hyg (Lond); 1975 Aug; 75(1):87-90. PubMed ID: 1056972 [TBL] [Abstract][Full Text] [Related]
18. Bacterial contamination of multiple-dose vials: a prevalence study. Mattner F; Gastmeier P Am J Infect Control; 2004 Feb; 32(1):12-6. PubMed ID: 14755229 [TBL] [Abstract][Full Text] [Related]